8.14
Precedente Chiudi:
$8.39
Aprire:
$8.5
Volume 24 ore:
30,231
Relative Volume:
0.05
Capitalizzazione di mercato:
$10.79M
Reddito:
$1.47M
Utile/perdita netta:
$-97.61M
Rapporto P/E:
-5.4631
EPS:
-1.49
Flusso di cassa netto:
$-80.90M
1 W Prestazione:
-4.80%
1M Prestazione:
-36.70%
6M Prestazione:
-13.22%
1 anno Prestazione:
-43.92%
Lyra Therapeutics Inc Stock (LYRA) Company Profile
Nome
Lyra Therapeutics Inc
Settore
Industria
Telefono
617-373-4600
Indirizzo
480 ARSENAL WAY, WATERTOWN, MA
Confronta LYRA con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
LYRA
Lyra Therapeutics Inc
|
8.14 | 13.11M | 1.47M | -97.61M | -80.90M | -1.49 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
472.27 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
564.64 | 61.80B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
328.00 | 42.46B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
591.74 | 35.22B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
296.46 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Lyra Therapeutics Inc Stock (LYRA) Upgrades & Downgrades
Data | Azione | Analista | Modifica della valutazione |
---|---|---|---|
2024-05-07 | Downgrade | BofA Securities | Buy → Underperform |
2024-05-07 | Downgrade | H.C. Wainwright | Buy → Neutral |
2024-05-07 | Downgrade | Jefferies | Buy → Hold |
2024-05-06 | Downgrade | William Blair | Outperform → Mkt Perform |
2023-10-06 | Ripresa | BTIG Research | Buy |
2023-08-31 | Iniziato | H.C. Wainwright | Buy |
2022-05-24 | Iniziato | Cantor Fitzgerald | Overweight |
2020-05-26 | Iniziato | BTIG Research | Buy |
2020-05-26 | Iniziato | BofA/Merrill | Buy |
2020-05-26 | Iniziato | Jefferies | Buy |
2020-05-26 | Iniziato | William Blair | Outperform |
Mostra tutto
Lyra Therapeutics Inc Borsa (LYRA) Ultime notizie
How high can Lyra Therapeutics Inc. stock price go in 2025Free Bull & Bear Market Updates - jammulinksnews.com
Is Lyra Therapeutics Inc. a good long term investmentUnstoppable trading performance - Autocar Professional
Lyra Therapeutics Inc. Stock Analysis and ForecastRobust investment performance - Autocar Professional
What analysts say about Lyra Therapeutics Inc. stockRobust financial gains - Autocar Professional
What drives Lyra Therapeutics Inc. stock priceExponential wealth increase - jammulinksnews.com
Lyra Therapeutics (LYRA) Proposes Sale of 846,744 Shares of Comm - GuruFocus
How Lyra Therapeutics Inc. stock performs during market volatilityFree Predictions - Newser
Why Lyra Therapeutics Inc. stock attracts strong analyst attentionConsistent High Return Strategy - beatles.ru
What makes Lyra Therapeutics Inc. stock price move sharplyFree Stock Market Courses - Newser
Lyra Therapeutics CFO Cavalier sells $6k in shares By Investing.com - Investing.com Canada
Lyra Therapeutics CEO Palasis sells $13944 in stock By Investing.com - Investing.com Nigeria
Lyra Therapeutics CEO Palasis sells $13944 in stock - Investing.com
Lyra Therapeutics (NASDAQ:LYRA) Downgraded to Sell Rating by Wall Street Zen - Defense World
Lyra Therapeutics (NASDAQ:LYRA) Stock Rating Upgraded by Wall Street Zen - Defense World
Lyra Therapeutics Announces Up to Approximately $15 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules - The Manila Times
Lyra Therapeutics Secures $4.3M in Direct Offering - TipRanks
Is Lyra Therapeutics, Inc. overvalued or undervalued? - MarketsMojo
Lyra Therapeutics regains Nasdaq compliance as stock maintains $1 minimum - Investing.com UK
Lyra Therapeutics: Regulatory Pathway For Non-Polyp Patients, An Underappreciated Catalyst - Seeking Alpha
Lyra Therapeutics, Inc. (NASDAQ:LYRA) Stake Lessened by Two Sigma Investments LP - Defense World
HC Wainwright Expects Higher Earnings for Lyra Therapeutics - Defense World
Lyra Therapeutics (LYRA) Upgraded to Buy: Here's Why - sharewise
H.C. Wainwright lifts Lyra Therapeutics stock target to $16 By Investing.com - Investing.com Canada
Lyra Therapeutics (LYRA) Price Target Raised by HC Wainwright & Co. | LYRA Stock News - GuruFocus
H.C. Wainwright Ups Target Price for Lyra Therapeutics (LYRA) to $16 | LYRA Stock News - GuruFocus
Lyra Therapeutics, Inc. (NASDAQ:LYRA) Shares Sold by Two Sigma Advisers LP - Defense World
Pre-market Movers: KLTO, TPST, PYPD, MOVE... - RTTNews
Lyra Stock Soars 356% in a Week on Strong Rhinosinusitis Study Success - MSN
Lyra Eyes US Filing For LYR-210 After Surprise ENLIGHTEN 2 Win - insights.citeline.com
Lyra Therapeutics Inc Azioni (LYRA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):